1 Max Planck Institute for Physiological and Clinical Research, Bad Nauheim, Germany
2 Mount Sinai Hospital, Samuel Lunenfeld Research Institute, Toronto, Canada
* Present address: Paul-Ehrlich-Institute, Langen, Germany
Present address: Laboratoire de génétique et physiologie du développement, IBDM- campus de Luminy, Marseille, France
These authors contributed equally to this work
In memoriam: Professor Werner Risau (18 December 1953-13 December 1998)
¶Author for correspondence (e-mail: nagy{at}mshri.on.ca)
Accepted 28 January 2002
![]() |
SUMMARY |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Key words: VEGFA, Vasculogenesis, Haematopoiesis, Visceral Endoderm, Mouse
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Previously performed, targeted gene inactivation studies clearly indicated an absolute requirement for VEGFA in early stages of embryonic development. These experiments showed that a 50% reduction in gene dose impairs vascular development and leads to embryonic lethality at mid-gestation (Carmeliet et al., 1996; Ferrara et al., 1996
). The distinct expression pattern during organogenesis (Breier et al., 1992
; Miquerol et al., 1999
) suggests that VEGFA may be involved in a multitude of developmental processes, including postnatal growth and survival (Gerber et al., 1999
).
Vasculogenesis, the main mechanism of vessel formation in early development, is based on the in situ formation of blood vessels from independently differentiating angioblasts. This process first takes place in the yolk sac (Risau and Flamme, 1995). The concomitant development of the first blood cells in this embryonic membrane facilitates nutrient supply to the embryo via the vitelline circulation. The simultaneous development of haematopoietic and endothelial cells, and the results of in vitro differentiation experiments (Choi et al., 1998
) suggest the existence of a common precursor, the haemangioblast, for these two lineages. The precursors of the yolk sac mesodermal component are located in the proximal epiblast. From there they migrate to their final extra-embryonic position (Lawson et al., 1991
) where they give rise to endothelial and haematopoietic cells. However, a crucial tissue transplantation experiment to detect such a bi-potential precursor population for these cells failed to confirm its existence, and suggested a clear segregation of the two lineages following mesodermal cell migration through the primitive streak (Kinder et al., 1999
). The two lineages, however, are connected through their dependence on VEGFR2, one of the VEGFA receptors. Targeted disruption of the Vegfr2 gene (Kdr Mouse Genome Informatics) resulted in a diverted migration of these cells to non-yolk sac mesodermal membranes such as the amnion (Shalaby et al., 1997
). As a consequence, both endothelial and blood cells were missing in the mutant yolk sac. Interestingly, however, the authors showed that VEGFR2-deficient ES (embryonic stem) cells did have the potential to differentiate into blood cells in vitro. This finding has been confirmed by independent studies (Schuh et al., 1999
; Hidaka et al., 1999
), and extrapolation to in vivo development suggests that VEGFR2 might not be essential for the initiation of haematopoietic differentiation up to 7.5 days of embryonic development, but it is required for later lineage expansion.
After establishment of blood islands in the yolk sac, the primary function of VEGFA/VEGFR2 signalling appears to be anti-apoptotic. Although a survival factor function for VEGFA has previously been described (Alon et al., 1995), Carmeliet et al. have recently resolved a distinct antiapoptotic pathway in early vascular development involving VE-cadherin and VEGFA/VEGFR2 (Carmeliet et al., 1999a
). Interference with this pathway is most probably the reason for the increased apoptosis of endothelial cells observed in the VEGFA loss-of-function mutation (Ferrara et al., 1996
).
Owing to the lethal haploinsufficiency of the Vegf (previously Vegfa) knockout, it was not possible to carry out the study of the homozygous deficient phenotype with standard methods. We bypassed this obstacle by aggregating homozygous Vegf/ ES cells with tetraploid wild-type embryos. This approach allowed the study of a completely ES cell-derived, VEGFA-deficient embryo proper (Carmeliet et al., 1996). These embryos were supported by wild-type extra-embryonic endoderm and trophoblast of the placenta. Therefore, the assay did not permit the investigation of the role of VEGFA in the extra-embryonic tissues. Interestingly, however, the extra-embryonic endoderm is one of the first tissues to express VEGFA during development (Miquerol et al., 1999
), starting at least 3 days earlier than the expression in the embryo proper.
Already in the late 1960s Miura and Wilt noticed that the extra-embryonic endoderm, as secretory epithelium was absolutely required for proper blood island formation (Miura and Wilt, 1969). This observation was confirmed by a later study that investigated Gata4/ embryoid bodies that could not form visceral endoderm. In this study, Bielinska et al. demonstrated that formation and organisation of blood islands was dependent on the presence of visceral endoderm (Bielinska et al., 1996
). These findings were extended by a report by Belaoussoff et al. (Belaoussoff et al., 1998
) showing that the visceral endoderm has an instructive function for haematopoietic and endothelial development during a narrow window of time. Only recently have the same group provided evidence that Indian hedgehog is one of the molecules derived from visceral endoderm that is responsible for the induction of endothelial and haematopoietic differentiation (Dyer et al., 2001
).
We have recently reported the generation of a lacZ knock-in into the 3'untranslated region (UTR) of the mouse Vegf gene (Miquerol et al., 1999) and VegflacZKI (Fig. 1A). This allele facilitated the characterisation of VEGFA expression at the cellular level both during development and in the adult organism. Interestingly, the modification of the gene resulted in a slight (two- to threefold) overexpression of VEGFA in the developing organs. The increased VEGFA expression was incompatible with normal heart development and resulted in homozygous embryonic lethality (Miquerol et al., 2000
). Together with the previously observed haploinsufficiency, this phenotype, which is due to slight overexpression, was a clear demonstration of minimal tolerance to alterations in VEGFA expression levels. The study of VEGFA expression in the yolk sac showed that both the visceral endoderm and the yolk sac mesodermal sheet express VEGFA (Miquerol et al., 1999
). These two layers sandwich the first site of blood and vessel formation of the embryo. This finding has raised the question of whether VEGFA expression in both layers is necessary or whether one of them would be sufficient for proper vessel and haematopoietic differentiation in the yolk sac. We address this question by a novel hypomorphic allele generated by a slightly modified insertion of lacZ into the 3' UTR of Vegf, distinct from the lacZ insertion reported previously (Miquerol et al., 1999
). The new allele (Vegflo; Fig. 1A) allowed heterozygous survival but conferred homozygous embryonic lethality by 9.0 dpc. In the homozygous embryos, the formation of blood islands in the yolk sac, as well as the development of the dorsal aortae, were severely defective.
|
![]() |
MATERIALS AND METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Generation of Vegflo+neo/+ ES cells and Vegflo+neo/+ and Vegflo/+ mice
The targeting vector was linearised with NotI and electroporated into R1 ES cells (Nagy et al., 1993). G418-resistant ES cell clones were screened by Southern blot using BglII digestion of the genomic DNA and a 400 bp BglII-EcoRI probe encompassing Vegf exon 3. Correct targeting was further confirmed by EcoRV digestion and hybridisation with a 1 kb HindIII probe derived from the Vegf 3' flanking region. Several independent clones were aggregated with CD-1 morulae as described before (Nagy and Rossant, 2000
). Germline transmission was obtained for two clones (B7 and C7). F1 progeny was subsequently bred to a deletor Cre recombinase transgenic mouse to delete the selectable marker cassette (Nagy et al., 1998
) and obtain Vegflo/+ mice. All further analysis was performed on a mixed CD-1/129 background.
Genotyping of mice carrying the targeted allele
Vegflo offspring were PCR genotyped using the following oligonucleotides: 5' stop, 5'-GAGCATTTATTCCCATGTCTG-3'; lacPCR, 5'-CATTACCAGTTGGTCTGGTG-3'; and fusionAS, 5'-CAGGCTTTCTGGATTAAGGAC-3'. These yielded fragments of 388 bp (wild type) and 163 bp (targeted allele). To distinguish the Vegflo and Vegflo+neo alleles, a sense oligonucleotide from the PGK pA (Neo, 5'-CCACATACACTTCATTCTCAG-3') and an antisense from lacZ (lacZ-276R, 5'-GATGGGCGCATCGTAACCGTGC-3') were used, resulting in amplification of a 1000 bp fragment from the Vegflo+neo allele.
Histological analysis, immunohistochemistry and in situ hybridisation
Embryos at different stages of development were dissected in cold PBS, fixed in 4% paraformaldehyde, paraffin-embedded and sectioned at 5 µm. Sections were stained with Haematoxylin/Eosin. Whole-mount immunohistochemistry using an antibody against PECAM-1 was performed as described (Davis, 1993). Procedures employed for detection of ß-galactosidase activity are described elsewhere (Miquerol et al., 1999
). Whole-mount in situ hybridisation and detection with AP-conjugated antibody was carried out according to the protocol published by Wilkinson and Nieto (Wilkinson and Nieto, 1993
). Probes were kindly provided by J. J. Bieker (EKLF); H. Stuhlmann (VEZF) and J. Rossant (VEGFR1 and VEGFR2).
RNA and protein analysis
Total RNA from embryos was prepared using Trizol Reagent (Life Technologies) according to the manufacturers instructions. Reverse transcription was performed on 1 µg of RNA using the oligonucleotide lacZ-276R 5'-GATGGGCGCATCGTAACCGTGC-3' and SuperscriptTM (Life Technologies) Reverse transcriptase at 55°C. The resulting cDNA was amplified using the oligonucleotides lacZ-276R and VEGF-D, 5'-GCCCTGGAGTGCGTGCCCACGTCAGAGAGCA-3'. The PCR product was gel purified and cloned into pGEM-T-easy (Promega) for subsequent dideoxy sequencing. Protein extracts were obtained by homogenising embryos in 250 mM Tris-HCl pH 7.8 and three cycles of freezing and thawing. Protein concentration was determined using the BioRad reagent. VEGF immunoreactive material was quantified with the Quantikine ELISA kit (R&D) according to the manufacturers instructions.
Embryo aggregations
Tetraploid embryos for aggregation experiments were generated as described (Nagy et al., 1993). Aggregation of diploid embryos or GFP+ ES cells (Hadjantonakis et al., 1998
) with tetraploid embryos was performed according to the protocol given elsewhere (Nagy and Rossant, 2000
). The resulting chimaeras were dissected at 8.5-9.5 dpc for subsequent analysis. For all chimaera experiments, small pieces of the embryo proper were removed for genotyping using the oligonucleotides given above.
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Electroporation into R1 ES cells (Nagy et al., 1993) yielded 12 correctly targeted clones (Southern blot analysis is shown in Fig. 1C). Germline transmission after ES cell/morula aggregation (Nagy and Rossant, 2000
) was achieved for two independent ES cell clones. Heterozygous animals were viable, fertile and did not show any obvious phenotypic alterations. As the selectable marker cassette was still present in these animals, they were subsequently bred to a general deletor strain of Cre mice (Nagy et al., 1998
), yielding viable offspring heterozygous for the neomycin-excised allele. Breeding these heterozygous mice with each other did not result in any live homozygous newborns. Subsequent analysis at different stages of embryonic development revealed that the homozygous embryos died between 8.5 and 9.0 dpc. Morphological evaluation of mutant embryos at 8.5-9.0 dpc showed the same defects as observed in Vegf+/ embryos: disorganised yolk sac vasculature with large lacunae and reduced lumina of the dorsal aortae (Fig. 2A-H). Sectioning demonstrated few and largely empty blood islands (Fig. 2I,J) and a reduction in the number of blood cells in the embryo proper, particularly noticeable in the sinus venosus (Fig. 2O,P). Development of the cardinal veins seems to proceed normally (Fig. 2M-P) and development of the heart is delayed; however, the endocardium is formed (Fig. 2M,N). To examine whether the impaired vascular development at the time of death results from regression of blood islands or defective recruitment of endothelial/haematopoietic precursors, we examined embryos at an earlier stage of development. Sections of mutant embryos at 8.0 dpc showed the same reduction in the number of blood islands devoid of primitive erythrocytes as observed at later stages, indicating that failure of precursor cell recruitment is the major cause for the defects in yolk sac vasculature (Fig. 2Q-T). The similarity to the Vegf+/ phenotype implicates a hypomorphic function of the knock-in allele that we therefore termed Vegf low (Vegflo).
|
|
|
Altered Vegf RNA production from the knock-in allele
In order to understand the molecular mechanisms of the embryonic lethality observed, the analysis of both the RNA and protein resulting from the targeted allele was performed. RT-PCR analysis using oligo dT-primed cDNA from homozygous mutant embryos and oligonucleotides bridging Vegf- and lacZ-coding sequences yielded a 616 bp instead of the expected 1217 bp product (Fig. 5C). Furthermore, we could not detect any RT-PCR product when a reverse primer in the exon 8-coding region was used (data not shown). Cloning and sequencing the 616 bp fragment revealed the absence of the exon 8-coding region as well as of the entire IRES (Fig. 5A, lowest panel). Therefore, the mRNA produced from the Vegf knock-in allele should be translated into a modified VEGFA protein, in which the exon 8 encoded six C-terminal amino acids are replaced by 66 amino acids derived from the lacZ-coding region (Fig. 5B). As the lacZ-coding sequence present in the predicted fusion protein is not in frame with VEGFA, this protein cannot confer ß-galactosidase activity. Surprisingly, although the entire IRES sequence is skipped in the process of splicing, ß-galactosidase activity is detectable in the knock-in embryos and adult mice, the expression pattern corresponds to that recently described for the VegflacZKI allele (data not shown) (Miquerol et al., 1999). Compared with measurements in wild-type littermates, a threefold increase in VEGFA immunoreactivity could be detected in the mutant embryos by ELISA (Fig. 5D). These results suggest that two different proteins can be translated from the chimaeric mRNA: a highly abundant C-terminally modified VEGFA and a functional ß-galactosidase, probably supported by the strong lacZ Kozak sequence (Kozak, 1999
).
|
Wild-type VEGFA expression in the visceral endoderm is sufficient for normal vessel formation and haematopoietic differentiation in the yolk sac
Previously, we have demonstrated that VEGFA is expressed both in the visceral endoderm and the yolk sac mesoderm at the time when vasculogenesis occurs (Miquerol et al., 1999). Using chimaera approaches, we have addressed the requirement for both sources of this growth factor for normal yolk sac development. Green fluorescent protein (GFP)-expressing (Hadjantonakis et al., 1998
) Vegf wild-type tetraploid embryos were aggregated with diploid Vegflo/lo embryos from the segregating F2 generation (Fig. 6A). In these chimaeras, the tetraploid component contributed only to the yolk sac visceral endoderm and the trophoblast lineages, while the diploid component contributed to all lineages, including the embryo proper. However, we often observed a few contaminating tetraploid cells in the gut of otherwise totally diploid embryos (Fig. 6B). Therefore, to establish the genotype of the diploid component of the chimaeras from each embryo proper recovered, we carefully removed a small part lacking GFP-positive cells for PCR analysis.
|
Rescue of blood island formation and vascular development was found in areas of the tetraploid (Vegf wild type) visceral endoderm (Fig. 6F-H,I,L). As the yolk sac mesoderm is Vegflo/lo in these chimaeras, this rescue indicates that the Vegf wild-type visceral endoderm is sufficient for normal blood and vessel formation in this membrane. In Vegflo/lo (ß-galactosidase positive) areas of visceral endoderm, the formation of blood islands is severely compromised (Fig. 6F-I,L).
The sections show that the range of rescue by VEGFA secreted from wild-type tetraploid areas is very short, reaching a distance of only a few cell diameters (marked by an asterisk in Fig. 6L). This notion was further supported by the observation that even extensive tetraploid contribution was not sufficient to rescue the intra-embryonic phenotype. All embryos showed the same small dorsal aortae lumen (arrows in Fig. 6J) and delayed heart development (Fig. 6K) as did unmanipulated Vegflo/lo embryos. Interestingly, however, the haematopoietic cell population in the embryo proper increased with increasing contribution of Vegf wild-type tetraploid cells to the yolk sac visceral endoderm (red arrows in Fig. 6J,K). This finding is in accordance with the previously published notion that the yolk sac blood islands are a major source of early haematopoietic cells colonising the embryo proper.
VEGFA is required in the visceral endoderm for hemangioblast formation
To test whether endoderm expression of VEGFA is necessary for normal blood island formation and vessel development in the yolk sac, we performed a reverse chimaera experiment by aggregating Vegflo/lo tetraploid embryos with Vegf wild-type, GFP-expressing ES cells (Fig. 7A). In this case, the yolk sac endoderm was completely derived from tetraploid Vegflo/lo embryos (easily detectable by ß-galactosidase staining, see Fig. 7C,G,H), whereas the entire extra-embryonic mesoderm, including endothelial and haematopoietic cells, was wild-type ES cell derived. As shown in Fig. 7B,C, the Vegf wild type, GFP-positive embryo proper developed normally until 9.5 dpc, the time of analysis. Histological sections revealed normal vessel formation along the entire embryo (arrowheads in Fig. 7F,I,J). However, only few blood cells could be observed in the AGM (aorta-gonad-mesonephros) region (Fig. 7F), the heart and the sinus venosus (Fig. 7I,J).
|
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Going beyond the knockout tetraploid setting, however, we created chimaeric yolk sac visceral endoderm by using Vegflo/lo embryos instead of ES cells as the diploid source. This approach allowed the study of wild-type and VEGFA-deficient essential lineages in the same embryo. Inspection of the chimaeric yolk sacs revealed that blood islands are only properly formed in areas where the visceral endoderm is composed of Vegf wild-type tetraploid cells, but not in Vegflo/lo patches of visceral endoderm. This observation already indicated that VEGFA activity derived from the visceral endoderm is a crucial element in blood island formation. Interestingly, rescue of blood island formation by wild-type visceral endoderm patches does not extend beyond a few cell diameters. Recently, Cleaver and Krieg identified Xenopus VEGF 122 as the chemotactic isoform that acts on dorsal aorta-forming angioblasts over a considerable distance (Cleaver and Krieg, 1998). From these data it could be hypothesised that the smallest VEGFA isoform mediates chemotaxis, whereas the heparin-bound VEGFA 164 and 188 act more locally and induce differentiation once the final destination in the yolk sac is reached. In our experimental set-up, diffusible VEGFA 120 secreted from wild-type visceral endoderm might be able to facilitate precursor migration even through Vegflo/lo patches, resulting in an even distribution of cells over the whole yolk sac. The local action of the higher molecular weight isoforms in wild-type patches then allows further expansion of blood islands that is inhibited in areas of Vegflo/lo visceral endoderm. If at least one VEGFA isoform could act over a distance of more than a few cell diameters (and therefore beyond Vegflo/lo patches), blood island formation would be expected to be blocked close to the boundaries of the visceral endoderm. Certainly it would be interesting to see how blood island formation proceeded in a set-up where embryos that lacked a single VEGFA isoform (Carmeliet et al., 1999b
) constitute the tetraploid component.
As yolk sac blood island formation was rescued by wild-type visceral endoderm, it was not surprising that the number of blood cells in the embryo proper was elevated with increasing contribution of wild-type visceral endoderm. Palis et al. have reported that definitive yolk sac derived erythroid and myeloid progenitors colonise the embryo with the onset of circulation (Palis et al., 1999). However, the still controversial issue of the relative contribution of yolk sac versus P-Sp (para-aortic splanchnopleura)/AGM-derived haematopoietic stem cells to foetal liver haematopoiesis (Keller et al., 1999
) could not be addressed with this approach, as the embryos were not viable beyond 9.5 dpc because of intra-embryonic vascular malformations.
Although VEGFA was initially characterised as endothelial specific mitogen, it is now accepted that it affects haematopoietic development through VEGFR2 as well. F1 Vegf+/ embryos display a severely reduced number of primitive erythrocytes in the yolk sac blood islands (Ferrara et al., 1996). Our analysis of the Vegflo/lo embryos led to similar findings. In vitro differentiation experiments have suggested an important function for VEGFA in blood cell differentiation. According to a report by Nakayama et al., emergence of progenitors for both the erythroid and lymphoid lineages in embryoid bodies is stimulated by VEGFA (Nakayama et al., 1998
). Choi et al. could demonstrate that blast colonies with haematopoietic and endothelial potential were formed from VEGFA-responsive embryonic precursors in vitro (Choi et al., 1998
). Additional experiments to assess the haematopoietic potential of VEGFA deficient progenitors are under way.
Failure of blood island formation in Vegflo/lo patches of chimaeric yolk sacs already indicated an important function of visceral endoderm-derived VEGFA. However, based on this first chimaeric approach, we could not exclude the possibility that VEGFA secreted by yolk sac mesoderm was involved in vasculogenesis in an autocrine manner. Until now Vegf/ or hypomorphic conceptuses, which are necessary for addressing the consequences of VEGFA malfunction in extra-embryonic tissues by tetraploid aggregations, were not available. The use of tetraploid Vegflo/lo embryos in combination with Vegf wild-type ES cells allowed us to investigate the effect of impaired VEGFA function in the visceral endoderm in a setting where the mesodermal target cell population was wild type. The failure of Vegflo/lo visceral endoderm to induce blood island formation properly in wild-type mesoderm convincingly demonstrates the intrinsic requirement for VEGFA in the yolk sac visceral endoderm. The importance of the visceral endoderm layer for proper blood island formation was discovered in the 1960s. Using chick embryos as a model system, Miura and Wilt found that although blood cells can differentiate in the absence of visceral endoderm, no endothelial cells and blood islands form. Trans-filter experiments suggested the involvement of soluble factors (Miura and Wilt, 1969). Our data now identify VEGFA as one of these factors. Using Gata4/ embryoid bodies that lack visceral endoderm, Bielinska et al. have reported that the visceral endoderm is essential for organisation of blood islands, but is not required for differentiation of primitive erythroblasts and endothelial cells (Bielinska et al., 1996
). More recently, Belaoussoff et al. have investigated the function of visceral endoderm in mouse embryo explant cultures. They showed a requirement for visceral endoderm signals in haematopoietic and vascular development. It also became clear that this process was restricted to the onset of gastrulation, a narrow time window between 6.0 and 6.5 dpc (Belaoussoff et al., 1998
). In the meantime, Dyer et al. have identified Indian hedgehog as a visceral endoderm-secreted factor that, alone, is sufficient to induce endothelial and haematopoietic differentiation in these cultures (Dyer et al., 2001
). However, to date there is no direct link between signalling leading to vascular and haematopoietic development and the hedgehog cascade. Thus, the nature of the interplay between factors secreted by the visceral endoderm remains to be determined. Interestingly, Indian hedgehog is expressed in a proximal-to-distal gradient in the visceral endoderm of gastrulation stage embryos (Dyer et al., 2001
) a pattern that might be consistent with findings that a spatial (as well temporal) order of recruitment of blood island progenitors is present (Kinder et al., 1999
). No such pattern has been established for visceral endoderm expression of VEGFA. Differences in the expression pattern of the VEGFA isoforms would be an attractive way in which to explain the movement of mesodermal precursor populations during gastrulation.
Regarding haematopoiesis, our chimaera approach might in perspective serve as a useful model for dissecting the contribution of extra- and intra-embryonic sites for definitive haematopoiesis. In tetraploid Vegflo/lo/wild-type GFP+ chimaeras the yolk sac haematopoiesis is completely abolished. Thus, it would certainly be interesting to investigate whether the embryos are viable beyond 9.5dpc, solely depending on intra-embryonic sites of definitive haematopoiesis.
Based on the data currently available on developmental expression and function of VEGFA and its receptors, as well as reports investigating the role of other molecules and tissues in gastrulation, the following model of blood island formation and vasculogenesis can be proposed. Mesodermal cells pre-destined to give rise to haematopoietic and/or endothelial cells (Nishikawa et al., 1998) leave the primitive streak attracted by VEGFA secreted from the yolk sac visceral endoderm (Shalaby et al., 1995
; Shalaby et al., 1997
). In the permissive environment of the yolk sac, they can complete their differentiation program. The haematopoietic and endothelial lineages can expand in response to VEGFA (Schuh et al., 1999
; Hidaka et al., 1999
) and their organisation into blood islands can be accomplished. During this process, VEGFR1 acts to restrict the expansion of the endothelial lineage (Fong et al., 1999
).
The availability of the VEGFA hypomorphic allele described here should now facilitate further dissection of the molecular mechanisms involved in migration and endothelial/haematopoietic differentiation processes during gastrulation. The use of specific developmental restrictions of components of chimaeric embryos, such as tetraploid conceptuses and ES cells, to direct mutant and wild-type cell towards defined allocations in chimaeras was found to be a powerful tool to uncover the intrinsic requirement for VEGFA expression in the visceral endoderm.
![]() |
ACKNOWLEDGMENTS |
---|
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Alon, T., Hemo, I., Itin, A., Peer, J., Stone, J. and Keshet, E. (1995). Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat. Med. 1, 1024-1028.[Medline]
Belaoussoff, M., Farrington, S. M. and Baron, M. H. (1998). Haematopoietic induction and respecification of A-P identity by visceral endoderm signaling in the mouse embryo. Development 125, 5009-5018.
Bielinska, M., Narita, N., Heikinheimo, M., Porter, S. B. and Wilson, D. B. (1996). Erythropoiesis and vasculogenesis in embryoid bodies lacking visceral yolk sac endoderm. Blood 88, 3720-3730.
Breier, G., Albrecht, U., Sterrer, S. and Risau, W. (1992). Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 114, 521-532.[Abstract]
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C. et al. (1996). Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435-439.[Medline]
Carmeliet, P., Lampugnani, M. G., Moons, L., Breviario, F., Compernolle, V., Bono, F., Balconi, G., Spagnuolo, R., Oostuyse, B., Dewerchin, M. et al. (1999a). Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 98, 147-157.[Medline]
Carmeliet, P., Ng, Y. S., Nuyens, D., Theilmeier, G., Brusselmans, K., Cornelissen, I., Ehler, E., Kakkar, V. V., Stalmans, I., Mattot, V. et al. (1999b). Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat. Med. 5, 495-502.[Medline]
Choi, K., Kennedy, M., Kazarov, A., Papadimitriou, J. C. and Keller, G. (1998). A common precursor for haematopoietic and endothelial cells. Development 125, 725-732.
Cleaver, O. and Krieg, P. A. (1998). VEGF mediates angioblast migration during development of the dorsal aorta in Xenopus. Development 125, 3905-3914.
Damert, A., Machein, M., Breier, G., Fujita, M. Q., Hanahan, D., Risau, W. and Plate, K. H. (1997). Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms. Cancer Res. 57, 3860-3864.[Abstract]
Davis, C. A. (1993). Whole-mount immunohistochemistry. Methods Enzymol. 225, 502-516.[Medline]
Dyer, M. A., Farrington, S. M., Mohn, D., Munday, J. R. and Baron, M. H. (2001). Indian hedgehog activates haematopoiesis and vasculogenesis and can respecify prospective neurectodermal cell fate in the mouse embryo. Development 128, 1717-1730.
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., OShea, K. S., Powell-Braxton, L., Hillan, K. J. and Moore, M. W. (1996). Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439-442.[Medline]
Fong, G. H., Klingensmith, J., Wood, C. R., Rossant, J. and Breitman, M. L. (1996). Regulation of flt-1 expression during mouse embryogenesis suggests a role in the establishment of vascular endothelium. Dev. Dyn. 207, 1-10.[Medline]
Fong, G. H., Zhang, L., Bryce, D. M. and Peng, J. (1999). Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice. Development 126, 3015-3025.
Gardner, R. L. (1984). An in situ cell marker for clonal analysis of development of the extraembryonic endoderm in the mouse. J. Embryol. Exp. Morphol. 80, 251-288.[Medline]
Gerber, H. P., Hillan, K. J., Ryan, A. M., Kowalski, J., Keller, G. A., Rangell, L., Wright, B. D., Radtke, F., Aguet, M. and Ferrara, N. (1999). VEGF is required for growth and survival in neonatal mice. Development 126, 1149-1159.
Hadjantonakis, A. K., Gertsenstein, M., Ikawa, M., Okabe, M. and Nagy, A. (1998). Generating green fluorescent mice by germline transmission of green fluorescent ES cells. Mech. Dev. 76, 79-90.[Medline]
Hidaka, M., Stanford, W. L. and Bernstein, A. (1999). Conditional requirement for the Flk-1 receptor in the in vitro generation of early haematopoietic cells. Proc. Natl. Acad. Sci. USA 96, 7370-7375.
Hirakow, R. and Hiruma, T. (1981). Scanning electron microscopic study on the development of primitive blood vessels in chick embryos at the early somite-stage. Anat. Embryol. 163, 299-306.[Medline]
Jang, S. K., Krausslich, H. G., Nicklin, M. J., Duke, G. M., Palmenberg, A. C. and Wimmer, E. (1988). A segment of the 5' nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J. Virol. 62, 2636-2643.[Medline]
Keller, G., Lacaud, G. and Robertson, S. (1999). Development of the haematopoietic system in the mouse. Exp. Haematol. 27, 777-787.[Medline]
Kinder, S. J., Tsang, T. E., Quinlan, G. A., Hadjantonakis, A. K., Nagy, A. and Tam, P. P. (1999). The orderly allocation of mesodermal cells to the extraembryonic structures and the anteroposterior axis during gastrulation of the mouse embryo. Development 126, 4691-4701.
Kozak, M. (1999). Initiation of translation in prokaryotes and eukaryotes. Gene 234, 187-208.[Medline]
Lawson, K. A., Meneses, J. J. and Pedersen, R. A. (1991). Clonal analysis of epiblast fate during germ layer formation in the mouse embryo. Development 113, 891-911.[Abstract]
Levy, A. P., Levy, N. S. and Goldberg, M. A. (1996). Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J. Biol. Chem. 271, 2746-2753.
Miquerol, L., Gertsenstein, M., Harpal, K., Rossant, J. and Nagy, A. (1999). Multiple developmental roles of VEGF suggested by a LacZ-tagged allele. Dev. Biol. 212, 307-322.[Medline]
Miquerol, L., Langille, B. L. and Nagy, A. (2000). Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression. Development 127, 3941-3946.
Miura, Y. and Wilt, F. H. (1969). Tissue interaction and the formation of the first erythroblasts of the chick embryo. Dev. Biol. 19, 201-211.[Medline]
Nagy, A., Rossant, J., Nagy, R., Abramow-Newerly, W. and Roder, J. C. (1993). Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc. Natl. Acad. Sci. USA 90, 8424-8428.
Nagy, A., Moens, C., Ivanyi, E., Pawling, J., Gertsenstein, M., Hadjantonakis, A. K., Pirity, M. and Rossant, J. (1998). Dissecting the role of N-myc in development using a single targeting vector to generate a series of alleles. Curr. Biol. 8, 661-664.[Medline]
Nagy, A. and Rossant, J. (2000). Production and analysis of ES cell aggregation chimaeras. In Gene Targeting: A Practical Approach. (ed. A.L.S.J.M.Joyner), pp. 177-206. New York: Oxford University Press.
Nakayama, N., Fang, I. and Elliott, G. (1998). Natural killer and B-lymphoid potential in CD34+ cells derived from embryonic stem cells differentiated in the presence of vascular endothelial growth factor. Blood 91, 2283-2295.
Neufeld, G., Cohen, T., Gengrinovitch, S. and Poltorak, Z. (1999). Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13, 9-22.
Nishikawa, S. I., Nishikawa, S., Hirashima, M., Matsuyoshi, N. and Kodama, H. (1998). Progressive lineage analysis by cell sorting and culture identifies FLK1+VE-cadherin+ cells at a diverging point of endothelial and hemopoietic lineages. Development 125, 1747-1757.
Palis, J., Robertson, S., Kennedy, M., Wall, C. and Keller, G. (1999). Development of erythroid and myeloid progenitors in the yolk sac and embryo proper of the mouse. Development 126, 5073-5084.
Risau, W. and Flamme, I. (1995). Vasculogenesis. Annu. Rev. Cell Dev. Biol. 11, 73-91.[Medline]
Schuh, A. C., Faloon, P., Hu, Q. L., Bhimani, M. and Choi, K. (1999). In vitro haematopoietic and endothelial potential of flk-1(/) embryonic stem cells and embryos. Proc. Natl. Acad. Sci. USA 96, 2159-2164.
Shalaby, F., Ho, J., Stanford, W. L., Fischer, K. D., Schuh, A. C., Schwartz, L., Bernstein, A. and Rossant, J. (1997). A requirement for Flk1 in primitive and definitive haematopoiesis and vasculogenesis. Cell 89, 981-990.[Medline]
Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X. F., Breitman, M. L. and Schuh, A. C. (1995). Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376, 62-66.[Medline]
Shima, D. T., Kuroki, M., Deutsch, U., Ng, Y. S., Adamis, A. P. and DAmore, P. A. (1996). The mouse gene for vascular endothelial growth factor. Genomic structure, definition of the transcriptional unit, and characterization of transcriptional and post-transcriptional regulatory sequences. J. Biol. Chem. 271, 3877-3883.
Southwood, C. M., Downs, K. M. and Bieker, J. J. (1996). Erythroid Kruppel-like factor exhibits an early and sequentially localized pattern of expression during mammalian erythroid ontogeny. Dev. Dyn. 206, 248-259.[Medline]
Takeuchi, T., Yamazaki, Y., Katoh-Fukui, Y., Tsuchiya, R., Kondo, S., Motoyama, J. and Higashinakagawa, T. (1995). Gene trap capture of a novel mouse gene, jumonji, required for neural tube formation. Genes Dev. 9, 1211-1222.[Abstract]
Wilkinson, D. G. and Nieto, M. A. (1993). Detection of messenger RNA by in situ hybridization to tissue sections and whole mounts. Methods Enzymol. 225, 361-373.[Medline]
Xiong, J. W., Leahy, A., Lee, H. H. and Stuhlmann, H. (1999). Vezf1: A Zn finger transcription factor restricted to endothelial cells and their precursors. Dev. Biol. 206, 123-141.[Medline]
Yamaguchi, T. P., Dumont, D. J., Conlon, R. A., Breitman, M. L. and Rossant, J. (1993). flk-1, an flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors. Development 118, 489-498.